Improvement of flow through arterial stenoses by drag reducing agents

Joseph L. Unthank, Stephen G. Lalka, J. Craig Nixon, Alan Sawchuk

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The potential of drag reducing polymers (DRP) to selectively improve blood flow through clinically significant arterial stenoses was investigated. An artificial stenosis of the left common iliac artery in dogs decreased left femoral artery pressure by 25%. High-molecular-weight polyacrylamide (PA) or polyethylene oxide (PEO) were infused at a slow constant rate while we measured left and right common iliac artery blood flows and left and right femoral artery and vein pressures. As DRP were infused, left iliac artery flow (QL) increased early and then decreased to baseline values as flow began to increase in the right iliac artery. The peak increase in QL was 24 ± 9% for PA and 46 ± 19% for PEO and occurred before right iliac artery flow (QR) increased. As additional polymer was infused, QR increased to a maximum of 41 ± 12 and 131 ± 40% with PA and PEO, respectively. Femoral artery pressures and hindlimb resistances tended to decrease in both limbs but the only significant differences occurred in the right (nonstenosed) side when QR was elevated. This study provides the first evidence that low concentrations of DRP might be capable of improving blood flow through stenotic blood vessels without altering flow in normal vessels. Although DRP might represent a new class of compounds that could be utilized in the treatment of cardiovascular diseases, the degree of variation in individual responses is a concern, the exact mechanism of action is unclear, and information on pharmacodynamics is lacking.

Original languageEnglish
Pages (from-to)625-630
Number of pages6
JournalJournal of Surgical Research
Volume53
Issue number6
DOIs
StatePublished - 1992

Fingerprint

Iliac Artery
Reducing Agents
Polymers
Pathologic Constriction
Femoral Artery
Pressure
Femoral Vein
Hindlimb
Blood Vessels
Cardiovascular Diseases
Extremities
Molecular Weight
Dogs
polyacrylamide

ASJC Scopus subject areas

  • Surgery

Cite this

Improvement of flow through arterial stenoses by drag reducing agents. / Unthank, Joseph L.; Lalka, Stephen G.; Nixon, J. Craig; Sawchuk, Alan.

In: Journal of Surgical Research, Vol. 53, No. 6, 1992, p. 625-630.

Research output: Contribution to journalArticle

Unthank, Joseph L. ; Lalka, Stephen G. ; Nixon, J. Craig ; Sawchuk, Alan. / Improvement of flow through arterial stenoses by drag reducing agents. In: Journal of Surgical Research. 1992 ; Vol. 53, No. 6. pp. 625-630.
@article{c0df9f43796546bbb5ca0834c5cfab8d,
title = "Improvement of flow through arterial stenoses by drag reducing agents",
abstract = "The potential of drag reducing polymers (DRP) to selectively improve blood flow through clinically significant arterial stenoses was investigated. An artificial stenosis of the left common iliac artery in dogs decreased left femoral artery pressure by 25{\%}. High-molecular-weight polyacrylamide (PA) or polyethylene oxide (PEO) were infused at a slow constant rate while we measured left and right common iliac artery blood flows and left and right femoral artery and vein pressures. As DRP were infused, left iliac artery flow (QL) increased early and then decreased to baseline values as flow began to increase in the right iliac artery. The peak increase in QL was 24 ± 9{\%} for PA and 46 ± 19{\%} for PEO and occurred before right iliac artery flow (QR) increased. As additional polymer was infused, QR increased to a maximum of 41 ± 12 and 131 ± 40{\%} with PA and PEO, respectively. Femoral artery pressures and hindlimb resistances tended to decrease in both limbs but the only significant differences occurred in the right (nonstenosed) side when QR was elevated. This study provides the first evidence that low concentrations of DRP might be capable of improving blood flow through stenotic blood vessels without altering flow in normal vessels. Although DRP might represent a new class of compounds that could be utilized in the treatment of cardiovascular diseases, the degree of variation in individual responses is a concern, the exact mechanism of action is unclear, and information on pharmacodynamics is lacking.",
author = "Unthank, {Joseph L.} and Lalka, {Stephen G.} and Nixon, {J. Craig} and Alan Sawchuk",
year = "1992",
doi = "10.1016/0022-4804(92)90265-2",
language = "English",
volume = "53",
pages = "625--630",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Improvement of flow through arterial stenoses by drag reducing agents

AU - Unthank, Joseph L.

AU - Lalka, Stephen G.

AU - Nixon, J. Craig

AU - Sawchuk, Alan

PY - 1992

Y1 - 1992

N2 - The potential of drag reducing polymers (DRP) to selectively improve blood flow through clinically significant arterial stenoses was investigated. An artificial stenosis of the left common iliac artery in dogs decreased left femoral artery pressure by 25%. High-molecular-weight polyacrylamide (PA) or polyethylene oxide (PEO) were infused at a slow constant rate while we measured left and right common iliac artery blood flows and left and right femoral artery and vein pressures. As DRP were infused, left iliac artery flow (QL) increased early and then decreased to baseline values as flow began to increase in the right iliac artery. The peak increase in QL was 24 ± 9% for PA and 46 ± 19% for PEO and occurred before right iliac artery flow (QR) increased. As additional polymer was infused, QR increased to a maximum of 41 ± 12 and 131 ± 40% with PA and PEO, respectively. Femoral artery pressures and hindlimb resistances tended to decrease in both limbs but the only significant differences occurred in the right (nonstenosed) side when QR was elevated. This study provides the first evidence that low concentrations of DRP might be capable of improving blood flow through stenotic blood vessels without altering flow in normal vessels. Although DRP might represent a new class of compounds that could be utilized in the treatment of cardiovascular diseases, the degree of variation in individual responses is a concern, the exact mechanism of action is unclear, and information on pharmacodynamics is lacking.

AB - The potential of drag reducing polymers (DRP) to selectively improve blood flow through clinically significant arterial stenoses was investigated. An artificial stenosis of the left common iliac artery in dogs decreased left femoral artery pressure by 25%. High-molecular-weight polyacrylamide (PA) or polyethylene oxide (PEO) were infused at a slow constant rate while we measured left and right common iliac artery blood flows and left and right femoral artery and vein pressures. As DRP were infused, left iliac artery flow (QL) increased early and then decreased to baseline values as flow began to increase in the right iliac artery. The peak increase in QL was 24 ± 9% for PA and 46 ± 19% for PEO and occurred before right iliac artery flow (QR) increased. As additional polymer was infused, QR increased to a maximum of 41 ± 12 and 131 ± 40% with PA and PEO, respectively. Femoral artery pressures and hindlimb resistances tended to decrease in both limbs but the only significant differences occurred in the right (nonstenosed) side when QR was elevated. This study provides the first evidence that low concentrations of DRP might be capable of improving blood flow through stenotic blood vessels without altering flow in normal vessels. Although DRP might represent a new class of compounds that could be utilized in the treatment of cardiovascular diseases, the degree of variation in individual responses is a concern, the exact mechanism of action is unclear, and information on pharmacodynamics is lacking.

UR - http://www.scopus.com/inward/record.url?scp=0027104345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027104345&partnerID=8YFLogxK

U2 - 10.1016/0022-4804(92)90265-2

DO - 10.1016/0022-4804(92)90265-2

M3 - Article

C2 - 1494298

AN - SCOPUS:0027104345

VL - 53

SP - 625

EP - 630

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 6

ER -